Loading…
Diabetic Testing Supply Access Act of 2014
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2014 · third_quarter · Civil Rights/Civil Liberties
Voting Rights Act Amendment (HR3899 and S1935)
Client expense: $32,000 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2014 · third_quarter · Civil Rights/Civil Liberties
Voting Rights Act Amendment (HR3899 & S1935)
Client expense: Not reported · Firm income: $32,976
Government targets: Bureau of the Census, HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2014 · second_quarter · Civil Rights/Civil Liberties
Legislative response to US Supreme Court decision in Vance v. Ball, State University in both house of Congress on 3/14 (S2133 & HR4227) Voting Rights Act Amendment (HR3899 & S1935)
Client expense: $56,393 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Medical/Disease Research/Clinical Labs
HR 962 / S 452 - Medicare Diabetes Prevention Act of 2013; HR 1074 / S 539 - National Diabetes Clinical Care Commission Act; HR 1257 - Preventing Diabetes in Medicare Act; HR 1274 / S 945 - Access to Quality Diabetes Education Act of 2013; S 557 - Medication Therapy Management Empowerment Act; HR 3322 - Eliminating Disparities in Diabetes Prevention, Access and cAre Act of 2013; HR 2845 / S 1935 - Diabetic Testing Supply Access of 2013/14; H.R. 3591 - Minority Diabetes Initiative Act; HR 2415 / S 1184 - Treat and Reduce Obesity Act of 2013; and S 596 - Fostering Independence Through Technology Act of 2013.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 962 / S. 452 - Medicare Diabetes Prevention Act of 2013 H.R. 1074 / S. 539 - National Diabetes Clinical Care Commission Act H.R. 1257 - Preventing Diabetes in Medicare Act H.R. 1274 / S. 945 - Access to Quality Diabetes Education Act of 2013 S. 557 - Medication Therapy Management Empowerment Act H.R. 3322 - Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2013 H.R. 2845 / S. 1935 - Diabetic Testing Supply Access of 2013/14 H.R. 3591 - Minority Diabetes Initiative Act H.R. 2415 / S. 1184 - Treat and Reduce Obesity Act of 2013 S. 596 - Fostering Independence Through Technology Act of 2013 H.R. 2524 / S. 1228 - Medicare Better Health Rewards Program Act of 2013
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Pharmacy
Fairness for Small Pharmacies in Part D Preferred Networks; Lifting Prohibition for Home Delivery of Diabetes Testing Supplies Home Delivery (H.R. 2845/S. 1935) ; S.644- The Preventing Abuse of Cough Treatments Act of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013;H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; TRICARE Pharmacy Benefit/Provisions; Medicaid Reimbursement Cuts; PBM audit and generic pricing transparency and pricing reform; S. 867 - Medicare Prescription Drug Program Integrity and Transparency Act of 2013; CMS proposed rule on Medicare Part D; H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013; H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54.
Client expense: $420,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE